Your browser doesn't support javascript.
loading
Isolated Psychiatric Symptoms in Children With Anti-N-Methyl-d Aspartate Receptor Encephalitis.
Gombolay, Grace; Brenton, J Nicholas; Yang, Jennifer H; Stredny, Coral M; Kammeyer, Ryan; Fisher, Kristen S; Sandweiss, Alexander J; Erickson, Timothy A; Kannan, Varun; Otten, Catherine; Steriade, Claude; Vu, NgocHanh; Santoro, Jonathan D; Robles-Lopez, Karla; Goodrich, Robert; Otallah, Scott; Arellano, Janetta; Christiana, Andrew; Morris, Morgan; Gorman, Mark P; Kornbluh, Alexandra B; Kahn, Ilana; Sepeta, Leigh; Jiang, Yike; Muscal, Eyal; Murray, Kristy O; Moodley, Manikum; Hardy, Duriel.
Afiliación
  • Gombolay G; Department of Pediatrics, Emory University SOM and Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: ggombol@emory.edu.
  • Brenton JN; Division of Pediatric Neurology, Department of Neurology, University of Virginia Health System, Charlottesville, Virginia.
  • Yang JH; Department of Pediatrics, University of California San Diego and Rady Children's Hospital San Diego, San Diego, California.
  • Stredny CM; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Kammeyer R; Department of Pediatrics, University of Colorado SOM and Children's Hospital Colorado, Denver, Colorado.
  • Fisher KS; Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Sandweiss AJ; Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Erickson TA; Section of Pediatric Tropical Medicine, Department of Pediatrics, Center for Human Immunobiology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas; Laboratories for Emerging and Tropical Diseases, School of Public Health, Texas A&M University, College Station, Texas.
  • Kannan V; Department of Pediatrics, Emory University SOM and Children's Healthcare of Atlanta, Atlanta, Georgia; Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Otten C; Department of Pediatrics, Seattle Children's/University of Washington, Seattle, Washington.
  • Steriade C; Department of Neurology, New York University SOM, New York, New York.
  • Vu N; Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Santoro JD; Department of Neurology and Pediatrics, Children's Hospital Los Angeles; Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Robles-Lopez K; Department of Pediatrics, University of Texas at Austin and Dell Medical School, Austin, Texas.
  • Goodrich R; Department of Neurology, Atrium Wake Forest Baptist Health, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Otallah S; Department of Neurology, Atrium Wake Forest Baptist Health, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Arellano J; Pediatric Neurology, Children's Hospital of Orange County, Orange, California.
  • Christiana A; Department of Neurology, New York University SOM, New York, New York.
  • Morris M; Department of Pediatrics, Emory University SOM and Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Gorman MP; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Kornbluh AB; Department of Pediatrics, Children's National Hospital, George Washington University Medical School, Washington, District of Columbia.
  • Kahn I; Department of Pediatrics, Children's National Hospital, George Washington University Medical School, Washington, District of Columbia.
  • Sepeta L; Department of Pediatrics, Children's National Hospital, George Washington University Medical School, Washington, District of Columbia.
  • Jiang Y; Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Muscal E; Division of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas; Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Murray KO; Section of Pediatric Tropical Medicine, Department of Pediatrics, Center for Human Immunobiology, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
  • Moodley M; Department of Pediatrics, University of Texas at Austin and Dell Medical School, Austin, Texas.
  • Hardy D; Department of Pediatrics, University of Texas at Austin and Dell Medical School, Austin, Texas.
Pediatr Neurol ; 159: 12-15, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39094249
ABSTRACT

BACKGROUND:

Isolated psychiatric symptoms can be the initial symptom of pediatric anti-N-methyl-d-aspartate (NMDA) receptor autoimmune encephalitis (pNMDARE). Here we report on the prevalence of isolated psychiatric symptoms in pNMDARE. We also assess whether initial neurodiagnostic tests (brain magnetic resonance imaging [MRI], electroencephalography [EEG], and/or cerebrospinal fluid [CSF] white blood cell count) are abnormal in children with isolated psychiatric symptoms and pNMDARE.

METHODS:

This multicenter retrospective cohort study from CONNECT (Conquering Neuroinflammation and Epilepsies Consortium) from 14 institutions included children under age 18 years who were diagnosed with pNMDARE. Descriptive statistics using means, medians, and comparisons for continuous versus discrete data was performed.

RESULTS:

Of 249 children included, 12 (5%) had only psychiatric symptoms without other typical clinical features of autoimmune encephalitis at presentation. All but one (11 of 12 = 92%) had at least one abnormal finding on initial ancillary testing eight of 12 (67%) had an abnormal EEG, six of 12 (50%) had an abnormal MRI, and five of 12 (42%) demonstrated CSF pleocytosis. The single patient with a normal MRI, EEG, and CSF profile had low positive CSF NMDA antibody (titer of 11), and symptoms improved without immunotherapy.

CONCLUSIONS:

Isolated first-episode psychiatric symptoms in pNMDARE are uncommon, and the majority of children will exhibit additional neurodiagnostic abnormalities. Delaying immunotherapy in a child with isolated psychiatric symptoms and normal neurodiagnostic testing may be warranted while awaiting confirmatory antibody testing.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Electroencefalografía / Encefalitis Antirreceptor N-Metil-D-Aspartato Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Electroencefalografía / Encefalitis Antirreceptor N-Metil-D-Aspartato Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2024 Tipo del documento: Article
...